In order to determine whether the expression of CTGF can be epigenetically regulated in NSCLC cells, we investigated whether DNMTs inhibition by 5-dAzaC would exert any effect on the CTGF mRNA level. The gene discussed is CCN2; the disease is non-small cell lung carcinoma.